Research report presented by UnivDatos, Emphasis on Products [Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), Devices (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUDs, Other Devices)]; Gender (Male, Females); Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy, Others), and Geographical analysis (key regions and countries).
As per the research report, The Global Contraceptive Drugs and Devices Market is expected to increase at a higher rate by 2027 expanding at a reasonable CAGR during the forecast period (2021-2027). Contraception is the use of various agents, drugs, devices, and surgical procedures for the prevention of unwanted pregnancy.
The global use and penetration of contraceptive drugs and devices is being driven by an increase in the number of unintended pregnancies, sexually transmitted diseases (STD) cases, and increased government initiatives. The industry will continue to expand as people become more knowledgeable of contraceptive pills. Female sterilisation is the most popular form of contraception used by women all over the world. In 2019, 23.7 percent of women, or 219 million women, use contraceptives. The other three most commonly used methods for preventing unintended pregnancy were male condoms (189 million), IUDs (159 million), and pills (151 million). The key ingredients of a contraception pill or birth control pill are hormones including progestin and oestrogen, which prevent the release of eggs or ova from the female ovaries. As a result, there is no fertilisation. Beyond preventing conception, there are many advantages of using contraceptive drugs, including reduced discomfort, clear skin, ovarian cyst protection, and a normal menstrual period.
For complete research, request for Sample of the report browse through – https://univdatos.com/request_form/form/368
COVID-19 has a significant effect on the development of the Contraceptive Drugs and Devices industry. This is largely attributed to a shortage of reproductive options. According to the WHO, COVID-19 has caused health programmes in abortion and family planning to be affected in seven out of ten countries. The production and supply chain for contraceptive pills has been severely disrupted, resulting in a drop in business growth. There will be stock outs of multiple contraception medications and products, including oral contraceptive tablets, contraceptives, copper intrauterine devices (IUDs), and depot medroxyprogesterone acetate, according to the United Nations Population Fund (UNFPA) (DMPA).
The industry is divided into two types of products: drugs and devices. The global contraceptive drugs and equipment industry is divided into three categories: oral contraceptives, topical contraceptives, and injectable contraceptives. Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUDs are the different types of contraceptive devices. Oral contraceptives account for the majority of the contraceptive drug market due to their high efficacy, ease of use, accessibility, and low cost. Condoms are more often utilised in terms of devices, leading to an uptick in the number of unintended births, STD incidents, and government measures. The industry is classified into Male and Female categories based on gender. Due to the increased commercialization of male birth control devices such as contraceptive injection for adults, the Male subsegment captured the majority of the industry. Due to an increase in unintended pregnancies, the female subsegment is also expected to develop rapidly.
For a detailed analysis of the COVID-19 Impact on Contraceptive Drugs and Devices Market browse through - https://univdatos.com/report/contraceptive-drugs-and-devices-market-current-analysis-and-forecast-2021-2027
The industry is divided into Hospitals & Clinics, Retail Pharmacy, Online Pharmacy, and Others based on the delivery system. Due to a rise in over-the-counter contraception drug purchases, the specialty pharmacy is projected to be the fastest-growing industry. North America (the United States, Canada, and the rest of North America), Europe (Germany, France, Italy, Spain, the United Kingdom, and the rest of Europe), Asia-Pacific (China, Japan, India, and the rest of APAC), and the rest of the world all had comprehensive analyses. In Eastern and South-Eastern Asia, IUDs account for 18.6% of contraceptive use, compared to 17.8% for pills and 14.6 percent for male condoms in Europe and Northern America.
Some of the major players operating in the market include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, and Sanofi, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Global Contraceptive Drugs and Devices Market Segmentation
Market Insight, by Products
Market Insight, by Gender
Market Insight, by Distribution Channel
Market Insight, by Region
Contraceptive Drugs and Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.